ALOFISEL Trademark

Trademark Overview


On Thursday, September 5, 2019, a trademark application was filed for ALOFISEL with the United States Patent and Trademark Office. The USPTO has given the ALOFISEL trademark a serial number of 79269427. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by TIGENIX, S.A.U.. The ALOFISEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; cellular, biological or bacteriological preparations for medical purposes, namely, for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants or engineered live cellular tissue for medical purposes, namely, for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients
alofisel

General Information


Serial Number79269427
Word MarkALOFISEL
Filing DateThursday, September 5, 2019
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6202635
Registration DateTuesday, November 24, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; cellular, biological or bacteriological preparations for medical purposes, namely, for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants or engineered live cellular tissue for medical purposes, namely, for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTakeda Pharmaceuticals International AG
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressCH

Party NameTIGENIX, S.A.U.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES

Party NameTIGENIX, S.A.U.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameTIGENIX, S.A.U.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Thursday, October 10, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, October 15, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, October 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 22, 2019APPLICATION FILING RECEIPT MAILED
Friday, December 6, 2019ASSIGNED TO EXAMINER
Friday, December 13, 2019NON-FINAL ACTION WRITTEN
Saturday, December 14, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 13, 2020REFUSAL PROCESSED BY MPU
Monday, January 13, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 31, 2020REFUSAL PROCESSED BY IB
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, February 24, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 26, 2021FINAL DISPOSITION PROCESSED
Friday, February 26, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, March 21, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 12, 2024INTERNATIONAL REGISTRATION RENEWED
Friday, February 28, 2025NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 28, 2025CHANGE OF OWNER RECEIVED FROM IB
Monday, November 24, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED